APA (7th ed.) Citation

Schroeder, T., Stelljes, M., Christopeit, M., Esseling, E., Scheid, C., Mikesch, J., . . . Kobbe, G. (2023). Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: The Azalena-Trial. Haematologica, 108(11), . https://doi.org/10.3324/haematol.2022.282570

Chicago Style (17th ed.) Citation

Schroeder, Thomas, et al. "Azacitidine, Lenalidomide and Donor Lymphocyte Infusions for Relapse of Myelodysplastic Syndrome, Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia After Allogeneic Transplant: The Azalena-Trial." Haematologica 108, no. 11 (2023). https://doi.org/10.3324/haematol.2022.282570.

MLA (9th ed.) Citation

Schroeder, Thomas, et al. "Azacitidine, Lenalidomide and Donor Lymphocyte Infusions for Relapse of Myelodysplastic Syndrome, Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia After Allogeneic Transplant: The Azalena-Trial." Haematologica, vol. 108, no. 11, 2023, https://doi.org/10.3324/haematol.2022.282570.